News
10-06-2012, 01:33 AM
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the National Cancer Institute.
More... (http://www.news-medical.net/news/20121006/Nelfinavir-inhibits-growth-of-HER2-positive-tumors.aspx)
More... (http://www.news-medical.net/news/20121006/Nelfinavir-inhibits-growth-of-HER2-positive-tumors.aspx)